| | |
PTI 05:04 PM | March 05,2009
Sales & Marketing function of big pharma will undergo dramatic changes over the next ten years
|
|
C.H. Unnikrishnan 11:01 PM | January 19,2009
Sales of prescription drugs contracted in October and November for the first time in four years
|
|
Radhieka Pandeya 11:00 PM | January 19,2009
Sebi requires Daiichi, which acquired 63.9% of Ranbaxy last November, to make an open offer to Zenotech because Ranbaxy holds a 46.95% stake in the firm
|
|
C.H. Unnikrishnan and Radhieka Pandeya 01:04 AM | January 19,2009
Growth to weaken due to rise in costs, low margins from global markets and deals, and mark-to-market losses
|
|
C.H. Unnikrishnan 12:41 AM | March 26,2008
The US standard has no monographs for antiretroviral drugs because of a strict patent regime there
|
|
06:35 AM | September 06,2007
So far, the domestic pharma industry has leveraged its scientific talent for immense success in the generics and, to a lesser extent, contract research markets
|
|
Bhuma Shrivastava 07:51 AM | August 09,2007
Health activists dismiss this as a stung industry complaining for being asked to toe the line
|
|
Colm Halpin 12:28 AM | August 03,2007
Pharma firms should work closely with customs authorities to intercept fake products
|
|